The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eye-catcher: Cement (pulmonary) embolism
Publications
Acute pulmonary embolism following -butyl-cyanoacrylate endoscopic injection sclerotherapy.
Annals of gastroenterology 2012;25;261 — 2012 — 261
Severe respiratory failure due to embolization of cyanoacrylate sclerosant.
QJM : monthly journal of the Association of Physicians 2014 Oct;107;831-2 — 2014 Oct — 831-2
Cyanoacrylate in the treatment of gastric varices complicated by multiple pulmonary emboli.
Internal medicine journal 2006 Jul;36;462-5 — 2006 Jul — 462-5
Fatal N-butyl-2-cyanoacrylate pulmonary embolism after sclerotherapy for variceal bleeding.
Endoscopy 2005 Jul;37;687 — 2005 Jul — 687